NASDAQ:HOLX

Hologic Stock Insider Trading

Healthcare > Medical - Instruments & Supplies

Buy HOLX

*Your capital is at risk

$76.01

+0 (+0%)

At Close: Jun 03, 2026

Hologic Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at -56.40. In total, the insiders bought 352.91K and sold 1.52M HOLX shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	-56.40
● Buy	352.91K shares
● Sell	1.52M shares
8% Buy Activity Strong Negative Correlation
Sell Signal High Confidence Apr 07, 2026 Analysis Breakdown: Strongly supported by a very low Insider Power Score of -56.4. Partially supported by a negative historical correlation. Confidence increased due to high data reliability score of 100. Supported by overwhelming sell-side pressure (8% buys).

Historical Insider Trades

Date	Type	Person	Role	Amount
Apr 07, 2026 Sell	Performance Stock Units D-Return	Liddy Anne M. General Counsel	Officer	3 452 Value: $0
Apr 07, 2026 Sell	Non-qualified Stock Option (Right to Buy) D-Return	Liddy Anne M. General Counsel	Officer	4 683 Value: $296.9K
Apr 07, 2026 Sell	Non-qualified Stock Option (Right to Buy) D-Return	Stamoulis Christiana Director	Director	6 816 Value: $285.7K
Apr 07, 2026 Sell	Common Stock D-Return	Stamoulis Christiana Director	Director	50 526 Value: $505
Apr 07, 2026 Sell	Non-qualified Stock Option (Right to Buy) D-Return	Stewart Stacey D. Director	Director	5 535 Value: $356.2K
Apr 07, 2026 Sell	Common Stock D-Return	Stewart Stacey D. Director	Director	8 358 Value: $84
Apr 07, 2026 Sell	Non-qualified Stock Option (Right to Buy) D-Return	Stewart Stacey D. Director	Director	4 536 Value: $346.2K
Apr 07, 2026 Sell	Non-qualified Stock Option (Right to Buy) D-Return	Stewart Stacey D. Director	Director	4 210 Value: $330.4K
Apr 07, 2026 Sell	Non-qualified Stock Option (Right to Buy) D-Return	Wendell Amy Mcbride Director	Director	4 536 Value: $346.2K
Apr 07, 2026 Sell	Non-qualified Stock Option (Right to Buy) D-Return	Wendell Amy Mcbride Director	Director	4 210 Value: $330.4K
Apr 07, 2026 Sell	Non-qualified Stock Option (Right to Buy) D-Return	Wendell Amy Mcbride Director	Director	5 055 Value: $359.1K
Apr 07, 2026 Buy	Performance Stock Units A-Award	Macmillan Stephen P Chairman, President And CEO	CEO / President	190 400 Value: $14.5M
Apr 07, 2026 Sell	Common Stock D-Return	Madaus Martin D Director	Director	5 445 Value: $54
Apr 07, 2026 Sell	Non-qualified Stock Option (Right to Buy) D-Return	Madaus Martin D Director	Director	1 016 Value: $77.0K
Apr 07, 2026 Sell	Non-qualified Stock Option (Right to Buy) D-Return	Mcmillan Wayde D. Director	Director	5 171 Value: $316.8K
Apr 07, 2026 Sell	Non-qualified Stock Option (Right to Buy) D-Return	Mohtashami Nanaz Director	Director	4 536 Value: $346.2K
Apr 07, 2026 Sell	Non-qualified Stock Option (Right to Buy) D-Return	Verstreken Jan Group President, International	CEO / President	12 490 Value: $510.2K
Apr 07, 2026 Sell	Non-qualified Stock Option (Right to Buy) D-Return	Verstreken Jan Group President, International	CEO / President	15 387 Value: $701.8K
Apr 07, 2026 Sell	Non-qualified Stock Option (Right to Buy) D-Return	Verstreken Jan Group President, International	CEO / President	12 509 Value: $855.0K
Apr 07, 2026 Sell	Non-qualified Stock Option (Right to Buy) D-Return	Verstreken Jan Group President, International	CEO / President	17 831 Value: $1.27M
Apr 07, 2026 Sell	Non-qualified Stock Option (Right to Buy) D-Return	Verstreken Jan Group President, International	CEO / President	20 056 Value: $1.44M
Apr 07, 2026 Sell	Common Stock D-Return	Verstreken Jan Group President, International	CEO / President	134 039 Value: $1K
Apr 07, 2026 Sell	Non-qualified Stock Option (Right to Buy) D-Return	Stamoulis Christiana Director	Director	5 293 Value: $372.0K
Apr 07, 2026 Sell	Performance Stock Units D-Return	Verstreken Jan Group President, International	CEO / President	31 409 Value: $0
Apr 07, 2026 Buy	Performance Stock Units A-Award	Schnittker Brandon President, Gyn Surgical	CEO / President	8 432 Value: $640.9K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT HOLOGIC

Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment in the United States, Europe, the Asia-Pacific, and internationally. It operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The company provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima vi...

Read Full Profile Here